CN Patent
CN1191252C — 3-位取代的喹诺酮衍生物及其在药学上的应用
Assigned to Institute of Materia Medica of CAMS and PUMC · Expires 2005-03-02 · 21y expired
What this patent protects
本发明公开了新的具有抗肿瘤活性的通式(I)的喹诺酮3-位被苯并咪唑、苯并噁唑和苯并噻唑取代化合物,本发明还公开了该类化合物的制备方法。
USPTO Abstract
本发明公开了新的具有抗肿瘤活性的通式(I)的喹诺酮3-位被苯并咪唑、苯并噁唑和苯并噻唑取代化合物,本发明还公开了该类化合物的制备方法。
Drugs covered by this patent
- Kalydeco (IVACAFTOR) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.